A detailed history of Qsemble Capital Management, LP transactions in Dexcom Inc stock. As of the latest transaction made, Qsemble Capital Management, LP holds 41,449 shares of DXCM stock, worth $3.15 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
41,449
Previous 4,638 793.68%
Holding current value
$3.15 Million
Previous $526 Million 428.42%
% of portfolio
0.51%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $2.36 Million - $4.27 Million
36,811 Added 793.68%
41,449 $2.78 Billion
Q2 2024

Aug 07, 2024

BUY
$110.31 - $140.45 $13,347 - $16,994
121 Added 2.68%
4,638 $526 Million
Q1 2024

May 07, 2024

BUY
$114.22 - $140.1 $515,931 - $632,831
4,517 New
4,517 $627 Million
Q4 2022

Feb 09, 2023

BUY
$84.98 - $122.67 $152,964 - $220,806
1,800 New
1,800 $204 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Qsemble Capital Management, LP Portfolio

Follow Qsemble Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Qsemble Capital Management, LP with notifications on news.